30 mg Octreotide Injection

Get a Price/Quote

MOQ : 100 Packs

30 mg Octreotide Injection Specification

Salt Composition
Octreotide Acetate 30 mg

Indication
Used for the treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, and other hormone-secreting tumors.

Dosage Form
Injection

Feature
Long-acting, controlled release formulation

Ingredients
Octreotide Acetate, Mannitol, Lactic Acid, Sodium Hydrogen Carbonate, Water for Injection

Application
For intramuscular use as directed by physician for certain tumor and hormone disorder treatments.

Ph Level
Approximately 4.5-7.5

Physical Color/Texture
White to off-white powder for suspension in a vial

Fermentation Smell
Odorless

Storage Instructions
Store in a refrigerator at 2C-8C. Do not freeze. Keep in original packaging to protect from light.

Shelf Life
24 months from manufacture date

Patient Suitability
Adult use only

Regulatory Approval
Complies with Indian pharmacopoeia standards

Reconstitution Requirement
Requires reconstitution with provided solvent before administration

Packaging Size
1 vial with solvent (for suspension) + package leaflet

International Brand
Sandostatin LAR (reference brand) / generic available

Precautions
To be administered under medical supervision only

Prescription/OTC Status
Prescription only

Route of Administration
Intramuscular injection

30 mg Octreotide Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 30 mg Octreotide Injection

Capitalise on the wondrous therapeutic potential of our 30 mg Octreotide Injection, renowned for its top-notch efficacy in treating acromegaly, carcinoid tumors, and hormone-secreting tumors. Garnering favorable reviews from leading healthcare professionals, this prescription-only, long-acting formulation ensures controlled release after intramuscular administration. Each package offers one vial with solvent, package leaflet, and complies with Indian pharmacopoeia standards. Purchase with confidence as this key therapy matches reference standard Sandostatin LAR. Administered under expert medical supervision, it's tailored for adult use, ensuring superior patient outcomes and regulatory compliance.

Competitive Edge & Key Features of 30 mg Octreotide Injection

This top-tier Octreotide Injection extends controlled-release action for up to four weeks, maximizing treatment intervals for adult patients with specified hormone-secreting tumors. Its favorable pH, odorless composition, and stability underscore its reliability and ease of use. Compatible with leading international brands, it enables effective reconstitution and administration, guaranteeing consistent dosing. Our product is supplied in tamper-proof packaging and is trusted by clinicians nationwide for its safety and efficacy in critical tumor management.

Sample Policy, Domestic Distribution, and Delivery Terms

Samples of 30 mg Octreotide Injection are provided upon request, subject to our established sample policy and prevailing regulations. We focus on India's main domestic market, offering reliable delivery services with competitive freight estimates. Shipments are processed directly from our central FOB port to ensure prompt arrival. Our team coordinates with buyers to estimate delivery timelines and costs, ensuring peace of mind and efficient distribution through trusted logistics partners.

FAQ's of 30 mg Octreotide Injection:

Q: How should the 30 mg Octreotide Injection be administered for optimal results?

A: The 30 mg Octreotide Injection must be reconstituted with the supplied solvent and administered as an intramuscular injection by a healthcare professional, following your physician's instructions.

Q: What are the primary therapeutic benefits of using this Octreotide Injection?

A: This injection offers long-acting control of symptoms in adults with acromegaly, carcinoid tumors, and other hormone-secreting tumors, ensuring sustained hormone regulation and improved patient outcomes.

Q: When should this Octreotide Injection be considered for treatment?

A: It is indicated for adults diagnosed with acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, or similar hormone-secreting conditions, as determined by a qualified physician.

Q: Where should the product be stored to maintain potency?

A: The injection must be stored in a refrigerator at 2C-8C, in its original packaging to protect it from light. Do not freeze the product to ensure its efficacy is preserved.

Q: What is the reconstitution process for this injection?

A: Before administration, the powder must be mixed with the included solvent according to the instructions provided in the package leaflet. Only a trained healthcare professional should perform this step prior to injection.

Tell us about your requirement